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Received January 3, 2014; accepted August 11, 2014AbstractBackground: Paravalvular leaks (PVLs) are a common complication of prosthetic valve replacement. Use of the transcatheter intervention
technique is a suitable alternative in high-risk patients who may not tolerate repeat surgery. Common reasons for failure of this demanding
intervention include poor imaging quality and unsuitable anatomy. The purpose of this study was to assess the usefulness and the incremental
value of real-time three-dimensional (RT 3D) transesophageal echocardiography (TEE) over two-dimensional (2D) TEE findings in the eval-
uation of the geometry and track of mitral PVLs during transcatheter closure.
Methods: Five patients with six mitral PVLs at high risk for repeat surgery underwent transcatheter leak closure. Intraoperative RT 3DTEE was
used to assess the location, shape, number, and size of the defects. Transapical approaches were used in all cases with fluoroscopic and RT 3D
TEE guidance of the wire and catheter, device positioning, and assessment of residual leak after the procedure.
Results: In all of the cases, defects with irregular crescent shapes and distorted tracks were clearly delineated by RT 3D TEE. This was compared
to those results obtained through 2D TEE, which was unable to characterize the defects. Three cases showed small leaks, which were completely
occluded with a patent ductus arteriosus (PDA) device in two cases, and a muscular ventricular septal defect (mVSD) occluder combined with
coil devices in one case. One case involved a large leak and early device embolization of the muscular VSD occluder, which was removed
surgically, and demonstrated a crescenteshaped defect. One patient had two releaks 2 months subsequent to the procedure due to two new
extended leaks at the tails of the crescenteshaped defect.
Conclusion: RT 3D TEE can clearly delineate the geometries of defects in their entirety, including shape, size, and location of the defect and
track canal. It would also appear that RT 3D TEE is superior to 2D TEE in the process of guiding the wire through the difficult canal anatomy,
facilitating the overall procedure. The small mitral PVLs can be completely occluded, but subsequent complications occurred with large defect
closures because of embolization or releak. Therefore, transcatheter closure of PVLs seems to be an attractive alternative for these patients, but
newer occluder designs that better conform to leak geometry will be required to improve outcomes.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Prosthetic valves at least several hundred thousand in
number (mechanic and bioprosthetic) are implanted each year.
However, paravalvular leaks (PVLs) may be detected in up to
5% of patients by echocardiography.1e5 PVLs are a common
complication of prosthetic valve replacement and occur mostociation. All rights reserved.
Fig. 1. Three-dimensional transesophageal echocardiography reconstructions
of an imaginary clock viewed from the left atrium with a mitral paravalvular
leak at the 2 o'clock position (broken line) with an irregular crescent shape and
a catheter (arrow) passed through. AO ¼ aorta; CS ¼ coronary sinus;
LAA ¼ left atrial appendage; TV ¼ tricuspid valve.
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leaks are usually asymptomatic, but some may cause heart
failure, arrhythmias, or hemolysis. Surgical reoperation carries
an increased challenge of PVLs and is associated with
considerable mortality and morbidity.6,7 Recently, several
small studies showed that percutaneous closure of PVLs is a
feasible option for patients who are not candidates for
surgery.6,7
However, the regurgitant jet produced by mitral PVLs has a
complex geometry between the prosthetic ring and the sur-
rounding native tissue. The shape and track of the defect
viewed by conventional two-dimensional transesophageal
echocardiography (2D TEE) imaging alone can be misleading,
resulting in procedural difficulties. However, the entire ge-
ometry of the mitral valve (MV) can be delineated by real-
time three-dimensional transesophageal echocardiography
(RT 3D TEE).8e11 Therefore, we attempted to determine
whether intraoperative 3D TEE provided the incremental
value over 2D TEE for the assessment of defect geometry
including the shape, size, track, and location of mitral PVLs.
2. Methods
After approval by the ethics committee of our hospital
(CHGH-IRB-103E-01) we reviewed patients who underwent
attempted PVL closure conducted from May 2012 to March
2013. Five patients with severe symptomatic mitral PVLs and
following poor results in palliative medical therapy at high risk
for repeat surgery underwent transcatheter leak closure. All
procedures were performed under general anesthesia in a
hybrid surgical room. In all cases, transapical approaches were
used under fluoroscopic and RT 3D TEE guidance.2.1. TEE examinationIntraoperative 2D TEE and RT 3D TEE were performed
with a 5.5 MHz new matrix array X7-2t transducer and a
commercially available Philips iE33 ultrasound system (Philips
Medical System, Andover, MA, USA) after induction of
anesthesia and endotracheal intubation. RT 3D TEE was per-
formed at the end of a comprehensive 2D TEE examination. RT
3D TEE can delineate the surgical view of the online MV
anatomy. Moreover, the mitral prosthesis images can be pre-
sented in the surgical view, in which the aortic valve is rotated
and positioned at 12 o'clock, making the left atrial appendage at
the 9 o'clock position. This allows for defining of the position of
a dehisced segment relative to this imaginary clock (Fig. 1). RT
3D TEE was not only able to assess the shape, size, track, and
location of mitral PVLs, but it was also able to provide guid-
ance of the wire and catheter, facilitate device positioning, and
assess residual leak after the procedure. Using 3D zoom mo-
dality, the entire mitral prosthesis can be seen “en face” and the
PVL orifices identified. The full volume modality allows the
demonstration of Doppler color flow through the leak site. TEE
is also crucial for detection of the presence of thrombi, peri-
cardial fluid, artifacts, and acoustic shadows during the
procedure.2.2. Device selectionThe device size was chosen to be 2 mm larger than the
minimal diameter of the defect. An Amplatzer coil, as well as
duct and muscular ventricular septal defect (VSD) occluders
(AGA Medical Corporation, North Plymouth, MN, USA),
were used for deployment.
3. Results
The devices were successfully and uneventfully implanted
in those five cases with six PVLs without any complication of
pericardial effusion, thrombosis formation, or neurologic
sequence. In this study, RT 3D TEE clearly delineated the
localization, shape, and size of the defect and the track of the
canal, which can be very difficult to engage and cross with the
guidewire (Fig. 1). In our cases, the majority position of mitral
PVLs occurred between 12 o'clock and 3 o'clock (anterior
more than posterior and septal more than lateral). The inci-
dence of mitral PVLs is no different between mechanical and
bioprosthetic valves, but occurs more often in patients with
combined mitral and aortic replacements (3 cases). The results
of these data are shown in Table 1. Two cases with small leaks
(<6 mm) were completely occluded by a duct occluder
(Fig. 2). One patient with a residual leak underwent muscular
VSD occluder implant and an additional coil device was
implanted to achieve complete closure (Fig. 3). One case had
an early embolization of the plug (12-mm VSD muscular
occluder) after implantation, which was successfully removed
surgically. Intraoperative findings revealed that the defect had
an irregular crescent shape (Figs. 1 and 4). In one case, two
Table 1
Procedure and results of paravalvular leak closures.
Age Sex Valve type (prosthesis) Size (mm) Locationa (o'clock) Device (mm) Outcome
70 M MVR (M) 12 3 mVSD (12) Early dislodged
83 M MVR þ AVR (B) 4 3 PDA (6  4) Complete closure
72 F MVR (M) 7 11 mVSD (8) þ coil (3) Complete closure
77 F MVR þ AVR (B) 3.8 12 PDA (6  4) Complete closure
59 M MVR þ AVR (M) 8 & 10 2 & 8 mVSD (8 & 10) Repeat surgery (2 mo later)
AVR ¼ aortic valve replacement; B ¼ bioprosthesis; M ¼ mechanical prosthesis; MVR ¼ mechanical valve replacement; mVSD ¼ muscular ventricular septal
defect; PDA ¼ patent ductus arteriosus.
a Surgical time clock.
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occluder at the 3 o'clock and 10 o'clock positions, respectively.
Unfortunately, releak and severe hematuria occurred 2 months
after the closure. Repeat surgery was performed, which
demonstrated that the two occluders were seated appropriately
at the leak site and proved difficult to remove by forceps
during surgery. Additionally, new extended residual leaks were
present around the occluders at both ends of the crescent
defect (Fig. 5). Thereafter, the patient died 1 week after sur-
gery because of persisted leak, hemolysis, and heart failure.
Follow-up of patients was conducted at a median of 120 days.
4. Discussion
PVLs are most commonly related to disruption of the
sewing ring sutures precipitated by infectious endocarditis,
which may be accompanied by abscess formation or signifi-
cant calcification and fibrotic scar of the annulus. Trans-
catheter closure of PVLs using an occluder device was first
described in 1992.1e5 Since that time, this technique has
slowly evolved with various technical improvements, and now
is a suitable alternative to repeat surgery in patients at high
surgical risk with appropriate defect geometries. The trans-
apical approach was chosen for our cases because it is more
suitable for PVL closure. The transapical approach can be an
alternative in cases of a failed attempt using the percutaneous
route or in cases with significant difficulties in the passage
through the leak canal. Crossing the leak with the guide wire
may be a challenge in some patients, especially those with
leak canals that are serpiginous. The utilization of 3D TEE isFig. 2. (A) Three-dimensional transesophageal echocardiography reconstruction of
A patent ductus arteriosus occluder, D, with a conical shape allowing the retention d
aortic valve; PMV ¼ prosthetic mitral valve.highly recommended to guide the procedure because it easily
depicts spatial orientation at any point during the intervention,
particularly facilitating the wiring of the defect as well as
confirming adequate device deployment.
Our cases demonstrated that PVLs most frequently
occurred at the anteroseptal aspect of the MV, especially in
patients with combined double-valve replacements. There are
two reasons that may account for this result. First, the ante-
roseptal aspect of the MV is a narrow, fibrous tissue band that
connects the aortic and mitral valve, also known as the aor-
tomitral curtain,12 which can increase the technical difficulty
of the approach to the surgical suture. In addition, patients
with aortic root infection or abscess formation are at a high
risk of developing PVLs. In our case series, such a leak was
not related to the prosthesis material, either mechanical or
biotissue. Our cases suggested that the shape and size of a
PVL might be a paramount factor in the success of the pro-
cedure, with smaller leaks (<6 mm) showing a higher success
rate for complete closure. The 3D images demonstrated that a
small leak was in an irregular tubular linear shape with a
distorted fistula tract and was easier to completely close using
a duct occluder as it becomes a tapering conical shape
allowing the retention disc to engage the distorted tract
(Fig. 2). The closure of PVLs with small leaks using an
Amplatzer duct occluder (AGA Medical Corporation) is
feasible for PVL closures. Although the Amplatzer duct
occluder lacks a retention rim on one side, which may
compromise stability, the distorted fistula tract of the leak may
deform the waist of the device to form a small retention ring
on the other end and tightly engage the neck of the PVL tract.the track of the mitral paravalvular leak with torturous canal (broken line). (B)
isc to engage the distorted tract at the narrow site of the track. PAV ¼ prosthetic
Fig. 3. (A) Two-dimensional color transesophageal echocardiography (3D TEE) showing a residual leak (L) after a muscular ventricular septal defect occluder (D in
figure) implanted. (B)The residual leak was completely occluded by an additional coil device, C. (C) The corresponding 3D color TEE image (en face LAview) from
image A. (D) The corresponding 3D TEE image (en face LA view) from image B. LA ¼ left atrium; LAA ¼ left atrial appendage; PMV ¼ prosthetic mitral valve.
Fig. 4. An embolization of device (D) was removed by forceps (F) during
surgery, demonstrating an irregular crescent shape mitral parvalvular defect.
PMV ¼ prosthetic mitral valve.
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along the round border of the mitral prosthetic ring form a
crescent defect or an irregular crescent shape (Figs. 2 and 3).
Due to the tension of the radial forces of the round waist of the
occluder inside the crescent-shaped defect, the leaks may
extend into the adjacent tissue in patients with previous in-
fections or annular calcifications, worsening the regurgitation
and causing recurrent regurgitation or even embolization13,14
(Fig. 3) despite various devices used to close them.
Because the tract of the crescent-shaped defect can be
parallel, perpendicular, or even tortuous, newer occluder de-
signs are required to conform to the unique shape15 and track
of each leak. Whereas transcatheter treatment of atrial septal
defects (ASDs) and patent foramen ovale (PFO) involves
closing a communication between two chambers on a similar
plane, mitral PVLs are asymmetrical in structure. As such, a
large retention disc of the device facilitates anchoring, but
carries a higher risk of interfering with the valve itself. The
Amplatzer muscular VSD occluder or duct occluder (AGA
Medical Corporation) have a smaller retention disc, so these
devices are favored in situations with close proximity to
Fig. 5. (A) Two-dimensional color transesophageal echocardiography (TEE) demonstrates two releaks' jets after two muscular ventricular septal defect (VSD)
occluders, D, were implanted for mitral paravalvular leaks (PVLs). (B) The corresponding three-dimensional color Doppler TEE image demonstrating location of
residual leak (R, arrow) next to implanted occluder (D in figure, broken lines). Surgical model of mitral PVLs with surgical removal of prosthetic mitral valve and
muscular VSD occluders. (C) Two residual leaks at two tails (white triangle line) of crescent-shaped defect fixed with round waist occluder. (D) A gap (broken
circle) formation between the prosthetic ring and device. D ¼ device; PMV ¼ prosthetic mitral valve.
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Vascular Plug III1 (AGA Medical Corporation) with an oval
disc and waist may provide better features for PVL closure.
Our findings suggest that until a newer occluder is designed
for the repair of larger leak defects, there is no single device
that can be used to completely accomplish leak closure. One
occluder, utilizing either the muscular VSD or Vascular Plug
III, combined with a coil to form a crescent shape, is necessary
to completely close a large leak (Fig. 4). To prevent a repeat
procedure due to a high incidence of residual leak, two wires
may be used to cross the leak site simultaneously in the event
the first attempt fails to completely occlude the defect. The
second wire serves as a backup so that if a residual leak oc-
curs, a coil occluder can be placed without difficulty. Over-
sized occluders should be avoided to prevent worsening of the
original leak.
In conclusion, PVL defects have more complex geometries
than ASDs, which make transcatheter closure of PVLs more
technically challenging compared to ASD and PFO closures,
even though similar occluders are used. Therefore, the high rate
of residual leak (approximately 40%) remains the main chal-
lenge with transcatheter closure of mitral PVLs. Even though
the study sample was small, the initial limited results appear to
suggest that this procedure currently may not be suitable for
those patients with a large PVL defect, and that 3D TEE could
be helpful for selecting suitable cases. However, our findings
are consistent with those of Hizazi,16 indicating that althoughtranscatheter closure of PVLs seems to be an attractive alter-
native for patients at high risk for repeat surgery, newer
designed occluders that better conform to leak geometry will be
necessary for improved outcomes.17,18 With the equipment
currently available, RT 3D TEE was shown to be superior to 2D
TEE in both its ability to more comprehensively characterize
defect geometry for case selection and to facilitate the
procedure.
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